Evidence map›Paper›PMID 18248663›Full record

ArticleAging cell2008

Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts.

Shuanhu Zhou, Joel S Greenberger, Michael W Epperly, Julie P Goff, Carolyn Adler, Meryl S Leboff, Julie Glowacki

Open access · bronzeAbstract read
In one paragraph

Article in Aging cell, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 395 papers.

0numbers the graph read from it
0cells of the map it votes in
395citing papers in PubMed
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

395 citing papers in PubMed, 790 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Bone Organoids: A Novel Tool for Modeling and Managing Skeletal Disorders in Diabetes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Impact of aging on CD146Frontiers in bioengineering and biotechnology · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

335 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shuanhu ZhouDepartment of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Joel S Greenberger
Michael W Epperly
Julie P Goff
Carolyn Adler
Meryl S Leboff
Julie Glowacki
Brigham and Women's Hospital · USUniversity of Pittsburgh · US

Funding

Effect of Aging &Vitamin D Status on OsteoblastogenesisR01AG025015 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI GLOWACKI, JULIANNE · 2004 to 2008
$1.9M
EFFECTS OF AGE ON SIGNALING IN HUMAN OSTEOBLASTOGENESISR01AG028114 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI GLOWACKI, JULIANNE · 2007 to 2010
$1.1M
NIA NIH HHS R01 AG 025015NIA NIH HHS R01 AG025015NIA NIH HHS R01 AG 028114NIA NIH HHS R01 AG028114
6 · The paper itself

Abstract

In vivo and in vitro studies indicate that a subpopulation of human marrow-derived stromal cells (MSCs, also known as mesenchymal stem cells) has potential to differentiate into multiple cell types, including osteoblasts. In this study, we tested the hypothesis that there are intrinsic effects of age in human MSCs (17-90 years). We tested the effect of age on senescence-associated beta-galactosidase, proliferation, apoptosis, p53 pathway genes, and osteoblast differentiation in confluent monolayers by alkaline phosphatase activity and osteoblast gene expression analysis. There were fourfold more human bone MSCs (hMSCs) positive for senescence-associated beta-galactosidase in samples from older than younger subjects (P < 0.001; n = 17). Doubling time of hMSCs was 1.7-fold longer in cells from the older than the younger subjects, and was positively correlated with age (P = 0.002; n = 19). Novel age-related changes were identified. With age, more cells were apoptotic (P = 0.016; n = 10). Further, there were age-related increases in expression of p53 and its pathway genes, p21 and BAX. Consistent with other experiments, there was a significant age-related decrease in generation of osteoblasts both in the STRO-1+ cells (P = 0.047; n = 8) and in adherent MSCs (P < 0.001; n = 10). In sum, there is an age-dependent decrease in proliferation and osteoblast differentiation, and an increase in senescence-associated beta-galactosidase-positive cells and apoptosis in hMSCs. Up-regulation of the p53 pathway with age may have a critical role in mediating the reduction in both proliferation and osteoblastogenesis of hMSCs. These findings support the view that there are intrinsic alterations in human MSCs with aging that may contribute to the process of skeletal aging in humans.

Indexed as

AdolescentAdultAgedAged, 80 and overApoptosisBone Marrow CellsCell DifferentiationCell ProliferationCellular SenescenceFemaleHumansMaleMesenchymal Stem CellsMiddle AgedOsteoblastsTumor Suppressor Protein p53Tumor Suppressor Protein p53

Identifiers

PMID18248663
PMCPMC2398731
OpenAlexW2077510301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.